Investigation of Arm Swings Characteristics in Patient With Chronic Obstructive Pulmonary Disease
Launched by HACETTEPE UNIVERSITY · Feb 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how arm movements change in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to healthy individuals. The researchers want to understand if and how these arm swings relate to balance, the severity of the disease, and overall posture in people with COPD. They will include 20 patients with COPD, who are stable and able to walk independently, as well as 20 healthy volunteers aged 40 to 65.
If you or a loved one have COPD and are interested in participating, you would need to be stable for the last month and not using any walking aids or receiving long-term oxygen therapy. During the trial, participants will complete various tests to assess their balance and walking ability, which will help researchers learn more about COPD and how it affects movement. This study aims to improve our understanding of the disease and support healthcare professionals in treating patients effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Who has been clinically stable for the last 4 weeks,
- • who will be able to walk independently for 6 minutes,
- • According to the Classification of Airflow Limitation in COPD (GOLD) system, the Stage is 1-2-3,
- • who declares that he has not taken part in any other research
- Exclusion Criteria:
- • walking assistive devices,
- • receiving chronic oxygen therapy,
- • with central and peripheral vestibular disease,
- • with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance,
- • with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery,
- • who has communication problems,
- • with mental and cognitive problems
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Aynur Demirel, PhD
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials